US Patent 11192877 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Patent 11192877 was granted and assigned to Novartis on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+74 characters)
Article
Patent abstract
The present disclosure provides a compound of Formula (I′):
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Artiom Cernijenko0
Claire Adcock0
Hasnain Ahmed Malik0
Kathryn Taylor Linkens0
Michael Scott Visser0
Noel Marie-France Thomsen0
Philip Lam0
Simone Bonazzi0
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111928770
Date of Patent
December 7, 2021
0Patent Application Number
165043750
Date Filed
July 8, 2019
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11192877 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11192877
Date of patent
December 7, 2021
Patent application number
16504375
Date Filed
July 8, 2019
Patent primary examiner
Find more entities like US Patent 11192877 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
